CEFOXITIN SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for cefoxitin sodium and what is the scope of freedom to operate?
Cefoxitin sodium
is the generic ingredient in seven branded drugs marketed by Acs Dobfar, Acs Dobfar Spa, Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Hospira Inc, B Braun, Pharmobedient, Merck, and Samson Medcl, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for cefoxitin sodium. Six suppliers are listed for this compound.
Summary for CEFOXITIN SODIUM
| US Patents: | 0 |
| Tradenames: | 7 |
| Applicants: | 10 |
| NDAs: | 18 |
| Drug Master File Entries: | 6 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Clinical Trials: | 1 |
| What excipients (inactive ingredients) are in CEFOXITIN SODIUM? | CEFOXITIN SODIUM excipients list |
| DailyMed Link: | CEFOXITIN SODIUM at DailyMed |
Recent Clinical Trials for CEFOXITIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| Alphacait, LLC | Phase 2 |
Pharmacology for CEFOXITIN SODIUM
| Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for CEFOXITIN SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for CEFOXITIN SODIUM
US Patents and Regulatory Information for CEFOXITIN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065012-001 | Jul 3, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065051-002 | Sep 11, 2000 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | MEFOXIN IN PLASTIC CONTAINER | cefoxitin sodium | INJECTABLE;INJECTION | 063182-001 | Jan 25, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| B Braun | CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER | cefoxitin sodium | INJECTABLE;INJECTION | 065214-001 | Mar 10, 2006 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hospira Inc | CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065313-001 | Jan 23, 2006 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch